SPACELAB LIFE SCIENCES-4, NEUROLAB NIH GUIDE, Volume 22, Number 27, July 30, 1993 ANNOUNCEMENT OF OPPORTUNITY AVAILABLE: NASA/NIH-94-001 P.T. 34 Keywords: Aerospace Biomedicine Brain Neuroscience Canadian Space Agency Centre National d'Etudes Spatiales European Space Agency Headquarters German Space Agency National Institute of Neurological Disorders and Stroke National Science Foundation National Space Development Agency of Japan National Aeronautics and Space Administration National Institute on Aging National Institute on Deafness and Other Communication Disorders Office of Naval Research Letter of Intent Receipt Date: October 1, 1993 Application Receipt Date: December 1, 1993 THE ANNOUNCEMENT OF OPPORTUNITY DESCRIBED IN THIS NOTICE CONTAINS ESSENTIAL INFORMATION FOR THE PREPARATION OF AN APPLICATION. POTENTIAL APPLICANTS MAY OBTAIN THE ANNOUNCEMENT FROM THE CONTACT NAMED IN INQUIRIES, BELOW. PURPOSE The National Aeronautics and Space Administration (NASA), in collaboration with several domestic and international partners, announces the opportunity for participation in scientific investigations in the weightless environment of the Space Shuttle. This is a Notice of Availability of an Announcement of Opportunity that solicits life sciences investigations in the neuroscience disciplines to be conducted in the Space Shuttle laboratory, Spacelab. The specific instructions and regulations governing the application format, submission, review, and award are defined in the Announcement. The President of the United States declared January 1990 as the beginning of the "Decade of the Brain." This Spacelab mission, titled "Neurolab," has been established as part of NASA's activities in the "Decade of the Brain." The primary goal is to advance scientific knowledge about the brain and the nervous system and apply that knowledge to maximize human potential. The purpose of this announcement is to offer the neuroscience community the opportunity to propose distinct and innovative research that requires the unique environment of space flight. ELIGIBILITY REQUIREMENTS All institutions, foreign and domestic, including universities, industry, NASA Centers, and other government agencies are eligible to submit applications. Applications from minority (U.S.) and women investigators are encouraged. MECHANISM OF SUPPORT For NIH applications, the administrative and funding instrument to be used for this program will be a cooperative agreement (U01), an assistance mechanism in which substantial NIH and other Federal government scientific, technical and/or programmatic involvement with the awardee is anticipated during performance of the activity; details are provided in the Announcement. For other partners, applications will be supported through appropriate mechanisms as defined by each partner. During the pre-award definition phase, NASA will facilitate and support the investigators and investigator teams in developing integrated protocols that are scientifically optimal and that will maximize the use of resources to support the goals of each investigator. FUNDS AVAILABLE It is estimated that six to eight awards will be made by the NIH, at an estimated total cost of $ 1.6 million for the first year of support, depending on receipt of a sufficient number of applications of high scientific merit and subject to the availability funds for this purpose. RESEARCH OBJECTIVES The investigations to be funded in response to this solicitation will be conducted on the Spacelab Life Sciences-4 (SLS-4) Neurolab mission planned for the first quarter of 1998. This mission will be between two to three weeks in duration. The experiments on this mission will be conducted primarily in the Spacelab module with limited use of the Shuttle Middeck. The Spacelab module will be configured to provide the resources required to conduct the selected neuroscience investigations. Implementation of investigations on this mission is limited by the Spacelab/Shuttle environment, available facilities and hardware, animal housing facilities, and utilization of crewmembers as experimental subjects or operators. These constraints are further defined in the announcement. Applications submitted in response to this announcement must address scientific questions that are related to the neuroscience theme and require the conditions of space flight. These conditions include: (1) microgravity and a changing G load during launch, flight, and reentry; (2) increased radiation; (3) altered temporal cues; (4) isolation and confinement; and (5) physiological and psychological changes associated with space flight and exposure to the space craft environment. The unique research environment provided by the Space Shuttle must be a necessary aspect of the proposed investigations. Studies are being solicited in the following research areas: o Cell and Molecular Neurobiology o Developmental Neurobiology o Sensory and Motor Systems o Central Nervous System Homeostasis and Adaptation o Behavior, Cognition, and Performance A detailed description of solicited research areas is provided in the announcement. LETTER OF INTENT Those persons interested in responding to this announcement may submit a letter of intent no later than October 1, 1993. The letter of intent should contain the name, title, affiliation, mailing address, and telephone number of the Principal Investigator; name, title, affiliation, mailing address, and telephone number of the Co- Investigators; and a descriptive title of the research. All domestic applicants may submit a letter of intent to: Neurolab Program Scientist AO No. NASA/NIH-94-001 Life and Biomedical Sciences and Applications Division Code UL NASA Headquarters Washington, DC 20546 Foreign Investigators may submit a letter of intent to the Neurolab Program Scientist and also to: International Relations Division Code IRD AO No. NASA/NIH-94-001 NASA Headquarters Washington, DC 20546 U.S.A. The letter of intent is for information and planning purposes only and is not binding. APPLICATION PROCEDURES A series of preapplication meetings will be held to provide potential applicants information to assist them in submitting an application. Presentations about previous flight experiments and information concerning the submission, review, award, and implementation of applications will be provided at these meetings. NASA officials will be available to answer questions and discuss issues raised by researchers. Attendance is open to all potential applicants. Additional information may be obtained from the staff listed in INQUIRIES. The preapplication meetings will be held at the following places and dates: North America August 23, 1993 Northwestern University, Evanston, Illinois Address further questions concerning this meeting to: Dr. David Liskowsky 300 D Street, SW, Suite 801 Washington, DC 20024 Telephone: (202) 488-5130 FAX: (202) 479-2613 Asia Held on July 21-22, 1993 Europe Held on August 3, 1993 Applications submitted in response to the announcement must be prepared in accordance with the General Instructions and Provisions provided in the Application for Public Health Service Grants, form PHS 398 (rev. 9/91). (Note: the instructions for Career Development and National Service Awards included in PHS 398 do not apply to Neurolab.) Failure to follow these instructions may preclude consideration of the application. Copies of the PHS 398 may be obtained from most institutional offices of sponsored research and the Office of Grants Information, Division of Research Grants, National Institutes of Health, Westwood Building, Room 449, Bethesda, MD 20892, telephone 301/710-0267. REVIEW CONSIDERATIONS Applications received in response to the Announcement will be evaluated in accordance with NIH review policies. The scientific peer review of the applications will be managed by the Division of Research Grants, NIH. The purpose of the initial review is to assess the scientific and technical merit of the applications in the context of the Announcement. Applications will be further reviewed by NASA and its partners for implementation feasibly and mission accommodation requirements. Based on the peer review evaluations and NASA's assessment of feasibility and accommodation requirements, applications will be selected for further definition. A team of researchers in each research area will be defined and investigator teams will be formed. The investigator teams will be responsible for developing integrated protocols to accommodate the goals of each investigator. Each investigation will be organized and conducted by an investigator team, rather than an individual investigator with an individually defined protocol. Final confirmation of selection and award will follow the completion of the experiment definition and mission feasibility studies. The fundamental goal of the investigation solicitation process is to identify unique ideas and capabilities that best suit the overall science objectives of the mission. The following criteria will be used in evaluating applications submitted in response to this announcement: o Scientific, technical, and/or medical significance and originality of the proposed research; o Appropriateness and adequacy of the experimental approach and methodology to be used; o Requirement for the space environment; o Qualifications for the Principal Investigator and staff in the area of the research and the Principal Investigator's prior research experience and record; o Adequacy of the available facilities and hardware required to carry out the investigation; o Reasonableness and adequacy of justification for the proposed budget and duration of support in relation to the proposed research; o Adequacy of the proposed means for protecting against adverse effects upon humans, vertebrate animals, and/or the environment; and o When human subjects are involved, the adequacy of plans for supporting ground-based research to involve a study population representative of the crew, which usually includes both men and women; Applications determined to be nonresponsive or noncompetitive will not receive detailed review and the applicant Principal Investigator and Institutional Official will be informed. AWARD CRITERIA Selection will be made from highly meritorious applications (as determined by the scientific evaluation) based on the following criteria: o Relevance to mission goals and objectives o Programmatic interest of the awarding agency; o Distribution of science among research areas on mission and use of resources; o Engineering feasibility as determined by separate engineering review. Schedule Letter of Intent Receipt Date: Oct 1, 1993 Application Receipt Date: Dec 1, 1993 Initial Selection of Investigators & Investigator Teams: Jun 1994 Experiment Definition: Jul 94-Jan 95 Revised Team Proposal: Jan 1995 Agency Review: Feb 1995 Final Selection Date: Jun 1995 INQUIRIES Direct requests for the Announcement and additional information about the preapplication meetings to: Andrew Monjan, Ph.D., M.P.H. National Institute on Aging Gateway Building, Suite 3C307 7102 Wisconsin Boulevard Bethesda, MD 20892 Telephone: (301) 496-9350 FAX: (301) 496-1494 Daniel A. Sklare, Ph.D. National Institutes on Deafness and Other Communication Disorders Executive Plaza South, Room 400-B 6120 Executive Boulevard Rockville, MD 20892 Telephone: (301) 402-3461 FAX: (301) 402-6251 William Heetderks, M.D., Ph.D. National Institute of Neurological Disorders and Stroke Federal Building, Room 916 Bethesda, MD 20892 Telephone: (301) 496-5745 Christopher Platt, Ph.D. National Science Foundation 1800 G Street, NW, Room 321 Washington, DC 20050 Telephone: (301) 357-7428 Joel L. Davis, Ph.D. Office of Naval Research 800 North Quincy Street Arlington, VA 22217-5660 Telephone: (703) 696-4744 Dr. Alan Mortimer Chief, Space Life Sciences Canadian Space Agency P.O. Box 7275 Station Ottawa, Ontario K1L8E2 CANADA Telephone: (613) 990-0801 Dr. Heinz Oser ESA Headquarters 8-10, rue Mario-Nikis F-75738 Paris Cedex 15 FRANCE Telephone: 33-14-273-7318 FAX: 33-14-273-7560 Dr. Antonio Guell CNES 18, Avenue Edouard-Belin 31055 Toulouse Cedex FRANCE Telephone: 33-61-28-2577 FAX: 33-61-28-2228 Dr. Shunji Nagaoka National Space Development Agency of Japan Tsukuba Space Center 2-1-1, Sengen Tsukuba, 305 JAPAN Telephone: 81-298-52-2773 FAX: 81-298-52-1597 Prof. Dr. Gunter Ruyters DARA (German Space Agency) Life Sciences Section (GN-WS3) Konigswinterer StraBe 522-524 P.O.Box 30 03 64 D-5300 Bonn 3 GERMANY Telephone: 49-228-447-214 FAX: 49-228-447-700 AUTHORITY AND REGULATIONS For NIH, this program is described in the Catalog of Federal Domestic Assistance No. 93.173. Awards are made under authorization of the Public Health Service Act, Title IV, Part A (Public Law 78-410, as amended by Public Law 99-158, 42 USC 241 and 285) and administered under PHS grants policies and Federal Regulations 42 CFR 52 and 45 CFR Part 74 (and 92 when applicable for state and local governments). This program is not subject to the intergovernmental review requirements of Executive Order 12372 or Health Systems Agency review. .
Return to NIH Guide Main Index
![]() |
Office of Extramural Research (OER) |
![]() |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
![]() |
Department of Health and Human Services (HHS) |
![]() |
||||